Merck announced on Friday that it is commencing, through a subsidiary, a cash tender offer to purchase all outstanding shares of common stock of Idenix Pharmaceuticals. On June 9, Merck announced its intent to acquire Idenix.
Valeant Pharmaceuticals International on Thursday announced the expiration of the tender offer by a subsidiary of Valeant Pharmaceuticals International to purchase all of the outstanding shares of Solta Medical for $2.92 per share in cash, without interest (less any applicable withholding taxes).
McKesson Corp. has reached an agreement with Franz Haniel & Cie. GmbH, currently representing a 50.01% stake in Celesio, to sweeten the purchase price for its shareholding in Celesio to EUR 23.50 per share.
CVS Caremark has announced the final results of its previously announced cash tender offers commenced on Nov. 26, 2012 of its 6.6% senior notes due 2019 and up to a maximum amount of its 6.125% senior notes due 2016 and 5.75% senior notes due 2017.
CVS Caremark has announced the expiration and final results of its previously announced tender offer for any and all of its $1 billion outstanding 6.302% enhanced capital advantaged preferred securities.